MENU

Hepcvir

Hepcvir (Sofosbuvir) Sofosbuvir is the first-in-class NS5B polymerase inhibitor for treating chronic Hepatitis C and to be used as a per oral combination anti-virus therapy such as pegylated

interferon and Ribavirin, or with Ribavirin alone. This drug can be use of as a combination therapy with other medicine and successfully administered for genotypes 1, 2, 3, and 4.